Highlight publications
Ferner, RE & Aronson, JK 2020, 'Chloroquine and hydroxychloroquine in covid-19', BMJ, pp. m1432. https://doi.org/10.1136/bmj.m1432
Ferner, R & Aronson, JK 2006, 'Clarification of terminology in medication errors: definitions and classification', Drug Safety, vol. 29, no. 11, pp. 1011-22. https://doi.org/10.2165/00002018-200629110-00001
McDowell, S, Coleman, J & Ferner, R 2006, 'Systematic review and meta-analysis of ethnic differences in risks of adverse recations to drugs used in cardiovascular medicine', British Medical Journal, vol. 332, no. 7551, pp. 1177-81. https://doi.org/10.1136/bmj.38803.528113.55
Recent publications
Article
Sanghvi, S, Ferner, RE, Scourfield, A, Urquhart, R, Amin, S, Hingorani, AD & Sofat, R 2023, 'How to assess pharmacogenomic tests for implementation in the NHS in England', British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15820
O'callaghan, S, Ferner, R, Barron, A, Saxby, K & Sofat, R 2022, 'Free-of-charge medicine schemes in the NHS: a local and regional drug and therapeutic committee's experience', British Journal of Clinical Pharmacology, vol. 88, no. 6, pp. 2571-2580. https://doi.org/10.1111/bcp.15094
Adeyere, E, Maniero, C, Magavern, E, Ferner, R & McGettigan, P 2022, 'Prescribing direct-acting oral anticoagulants - mind the evidence gap', British Journal of Clinical Pharmacology, vol. 88, no. 11, pp. 4724-4731. https://doi.org/10.1111/bcp.15450
Ferner, R, Stevens, R, Anton, C & Aronson, J 2022, 'Spontaneous reporting to regulatory authorities of suspected adverse drug reactions to COVID-19 vaccines over time: the effect of publicity', Drug Safety, vol. 45, no. 2, pp. 137-144. https://doi.org/10.1007/s40264-021-01138-z
Ferner, R, Mason, J, Vallance, H, Choudhary, T, Marriott, J, Coleman, J & Pontefract, S 2021, 'Coping with COVID: preparing prescribers during the pandemic', British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15153
Ferner, R 2021, 'Medicines and murder', The Medico-legal journal, vol. 89, no. 2, pp. 84-92. https://doi.org/10.1177/0025817221989573
Cox, AR & Ferner, R 2021, 'Tramadol: repeated prescriptions and repeated warnings', BMJ evidence-based medicine, vol. 26, no. 6, pp. E17. https://doi.org/10.1136/bmjebm-2020-111661
Ferner, R & Pucci, M 2020, 'Adverse drug reactions', Medicine, vol. 48, no. 7, pp. 443-449. https://doi.org/10.1016/j.mpmed.2020.04.010
Sanghvi, S, Allen, R, Cho, S, Ferner, RE, Urquhart, R & Sofat, R 2020, 'Are high-cost drug funding mechanisms fit for purpose? A retrospective study of individual funding requests in an NHS tertiary hospital', British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.14409
Aronson, JK & Ferner, RE 2020, 'Drugs and the renin-angiotensin system in covid-19', BMJ, pp. m1313. https://doi.org/10.1136/bmj.m1313
Review article
Aronson, JK, Heneghan, C & Ferner, RE 2023, 'Drug shortages. Part 1. Definitions and harms', British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15842
Aronson, JK, Heneghan, C & Ferner, RE 2023, 'Drug shortages. Part 2: Trends, causes and solutions', British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15853
Ferner, RE & Aronson, JK 2022, 'Medicines legislation and regulation in the United Kingdom 1500-2020', British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15497
Ferner, R, Day, R & Bradberry, S 2022, 'Phenytoin and damage to the cerebellum - a systematic review of published cases', Expert Opinion on Drug Safety, vol. 21, no. 7, pp. 957-977. https://doi.org/10.1080/14740338.2022.2058487
Bennett, F, Ferner, R & Sofat, R 2021, 'Overprescribing and rational therapeutics: barriers to change and opportunities to improve', British Journal of Clinical Pharmacology, vol. 87, no. 1, pp. 34-38. https://doi.org/10.1111/bcp.14291